Efficacy and Durability of Intravenous Ertapenem Therapy for Recalcitrant Hidradenitis Suppurativa

CONCLUSIONS AND RELEVANCE: In this retrospective review of medical records and telephone survey, treating HS with intravenous ertapenem, administered for a mean of 13 weeks, was associated with improvement in clinical and inflammatory markers, as well as heightened patient satisfaction. Nonetheless, this approach should be monitored for the emergence of antimicrobial resistance given a longer than standard treatment course.PMID:38353987 | PMC:PMC10867774 | DOI:10.1001/jamadermatol.2023.6201

Source: Pain Physician - February 14, 2024 Category: Anesthesiology Authors: Avigdor Nosrati Peter Y Ch'en McCall E Torpey Neda Shokrian Gretchen Ball Gabrielle Benesh Tyler M Andriano Tian Ran Zhu Haley D Heibel H Dean Hosgood Kristina L Campton Steven R Cohen Source Type: research